Skip to main content

Advertisement

Log in

Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The aim of this study was to characterize the phenotype and treatment of young patients (manifestation <30 years) with diabetes of mitochondrial origin (DMO), based on the German/Austrian DPV (Diabetes Patienten Verlaufsdokumentation) registry. Only 13 (0.02 %) of all patients with diabetes in this cohort were identified with DMO, mainly due to the Kearns-Sayre (n = 5), Pearson (n = 3), or mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome (n = 2). The onset of DMO (14.2, interquartile range (IQR) 7.1–16 years) was later than diabetes onset in individuals with T1D but earlier than in T2D. At manifestation, patients exhibited a mild elevation of blood glucose concentrations (251, IQR 178–299 mg/dl) without ketoacidosis. They had lower body mass index (BMI) values (−1.39 ± 0.28 kg/m2) than peers with T1D or T2D (p < 0.0001) and higher triglycerides (211, IQR 134–574 mg/dl) than in T1D (p = 0.04) while there was a high rate of dyslipidemia (86 %). Insulin requirements (0.58, IQR 0.37–0.90 U/kg/d) were between T1D and T2D while glucometabolic control (glycated hemoglobin A1c (HbA1c) 7.4 ± 0.52 %) in DMO was comparable to age-matched T2D and stable over a 5-year follow-up.

Conclusion: Primary mitochondrial disorders are a rare cause of juvenile diabetes and likely to be underdiagnosed. As there is clinical overlap with T1D and T2D, dyslipidemia and low body weight may help to identify further DMO cases.

What is Known:

In adults diabetes of mitochondrial origin (DMO) is a rare cause of non-autoimmune diabetes, affecting about 0.8 % of diabetes cases.

Common features are a maternal family history of diabetes, hearing loss and neurological abnormalities.

What is New:

In our juvenile cohort 0.02 % of diabetes patients (age < 30 years) were affected by DMO, while Kearns Sayre, MELAS and Pearson syndrome were the most frequent entities.

Juvenile DMO patients exhibited dyslipidemia, higher triglycerides and a lower BMI than peers with T1D or T2D, while some patients also showed retinal changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

DMO:

Diabetes of mitochondrial origin

DPV:

Diabetes Patienten Verlaufsdokumentation

HbA1c:

Glycated hemoglobin A1c

IQR:

Interquartile range

KSS:

Kearns-Sayre syndrome

MELAS:

Syndrome mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes

MIDD:

Maternally inherited diabetes and deafness

T1D:

Type 1 diabetes mellitus

T2D:

Type 2 diabetes mellitus

SD:

Standard deviation

References

  1. Abad MM, Cotter PD, Fodor FH, Larson S, Ginsberg-Fellner F, Desnick RJ (1997) Screening for the mitochondrial DNA A3243G mutation in children with insulin-dependent diabetes mellitus. Metabolism 46:445–449

    Article  CAS  PubMed  Google Scholar 

  2. Blake R, Trounce IA (2014) Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta 1840(4):1404–12

  3. Donaghue KC, Wadwa RP, Dimeglio LA, Wong TY, Chiarelli F, Marcovecchio ML, Salem M, Raza J, Hofman PL, Craig ME (2014) Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 15(S20):257–269

    Article  CAS  PubMed  Google Scholar 

  4. Finsterer J, Segall L (2010) Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 33(2):138–151

    Article  CAS  PubMed  Google Scholar 

  5. Frenzel CB, Das AM, Marg W (2001) Mitochondriopathie bei einem Kind mit Shwachman-Syndrom und Zöliakie. Monatsschr Kinderheilkd 149:377–381

    Article  Google Scholar 

  6. Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M (1995) Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1271(1):253–260

    Article  PubMed  Google Scholar 

  7. Gerstl EM, Rabl W, Rosenbauer J, Gröbe H, Hofer SE, Krause U, Holl RW (2008) Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27.035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 167(4):447–453

    Article  CAS  PubMed  Google Scholar 

  8. Goli AK, Goli SA, Byrd RP Jr, Roy TM (2002) Simvastatin-induced lactic acidosis: a rare adverse reaction? Clin Pharmacol Ther 72(4):461–464

    Article  PubMed  Google Scholar 

  9. Guillausseau PJ, Dubois-Laforgue D, Massin P, Laloi-Michelin M, Bellanné-Chantelot C, Gin H, Bertin E, Blickle JF, Bauduceau B, Bouhanick B, Cahen-Varsaux J, Casanova S, Charpentier G, Chedin P, Derrien C, Grimaldi A, Guerci B, Kaloustian E, Lorenzini F, Murat A, Olivier F, Paques M, Paquis-Flucklinger V, Tielmans A, Vincenot M, Vialettes B, Timsit J, GEDIAM, Mitochondrial Diabetes French Study Group (2004) Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab 30(2):181–186

    Article  CAS  PubMed  Google Scholar 

  10. Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, Bertin E, Blickle JF, Bouhanick B, Cahen J, Caillat-Zucman S, Charpentier G, Chedin P, Derrien C, Ducluzeau PH, Grimaldi A, Guerci B, Kaloustian E, Murat A, Olivier F, Paques M, Paquis-Flucklinger V, Porokhov B, Samuel-Lajeunesse J, Vialettes B (2001) Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 134(9 Pt 1):721–728

    Article  CAS  PubMed  Google Scholar 

  11. Ho J, Pacaud D, Rakic M, Khan A (2014) Diabetes in pediatric patients with Kearns-Sayre syndrome: clinical presentation of 2 cases and a review of pathophysiology. Can J Diabetes 38(4):225–228

    Article  PubMed  Google Scholar 

  12. Holl RW, Karges B, Rosenbauer J, Meissner T, Kapellen T, Icks A, Schober E (2013) Häufige und seltene diabetesformen in der pädiatrischen Diabetologie: Ergebnisse des DPV-Registers im BMBF-Kompetenznetz Diabetes. Diabetes Stoffwechsel Herz 22:42

    Google Scholar 

  13. Hosszúfalusi N, Karcagi V, Horváth R, Palik E, Várkonyi J, Rajczy K, Prohászka Z, Szentirmai C, Karádi I, Romics L, Pánczél P (2009) A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern. Diabetes Metab Res Rev 25(2):127–135

    Article  PubMed  Google Scholar 

  14. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330(14):962–968

    Article  CAS  PubMed  Google Scholar 

  15. Karaa A, Goldstein A (2015) The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes 16(1):1–9

    Article  PubMed  Google Scholar 

  16. Kishimoto M, Hashiramoto M, Araki S, Ishida Y, Kazumi T, Kanda E, Kasuga M (1995) Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetologia 38(2):193–200

    Article  CAS  PubMed  Google Scholar 

  17. Koenig MK (2008) Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol 38(5):305–313

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V, Hippel V, Jaeger U, Johnsen D, Kiess W, Korte W, Kunze D, Menner K, Müller M, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Hebebrand J (2001) Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatschr Kinderheilkd 149(8):807–818

    Article  Google Scholar 

  19. Laloi-Michelin M, Meas T, Ambonville C, Bellanné-Chantelot C, Beaufils S, Massin P, Vialettes B, Gin H, Timsit J, Bauduceau B, Bernard L, Bertin E, Blickle JF, Cahen-Varsaux J, Cailleba A, Casanova S, Cathebras P, Charpentier G, Chedin P, Crea T, Delemer B, Dubois-Laforgue D, Duchemin F, Ducluzeau PH, Bouhanick B, Dusselier L, Gabreau T, Grimaldi A, Guerci B, Jacquin V, Kaloustian E, Larger E, Lecleire-Collet A, Lorenzini F, Louis J, Mausset J, Murat A, Nadler-Fluteau S, Olivier F, Paquis-Flucklinger V, Paris-Bockel D, Raynaud I, Reznik Y, Riveline JP, Schneebeli S, Sonnet E, Sola-Gazagnes A, Thomas JL, Trabulsi B, Virally M, Guillausseau PJ, Mitochondrial Diabetes French Study Group (2009) The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab 94(8):3025–3030

    Article  CAS  PubMed  Google Scholar 

  20. Laloi-Michelin M, Virally M, Jardel C, Meas T, Ingster-Moati I, Lombès A, Massin P, Chabriat H, Tielmans A, Mikol J, Guillausseau PJ (2006) Kearns Sayre syndrome: an unusual form of mitochondrial diabetes. Diabetes Metab 32(2):182–186

    Article  CAS  PubMed  Google Scholar 

  21. Liou CW, Huang CC, Lin TK, Tsai JL, Wei YH (2000) Correction of pancreatic beta-cell dysfunction with coenzyme Q(10) in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome and diabetes mellitus. Eur Neurol 43(1):54–55

    Article  CAS  PubMed  Google Scholar 

  22. Maassen JA, ‘T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, Raap AK, Janssen GM, Lemkes HH (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53:S103–S109

    Article  CAS  PubMed  Google Scholar 

  23. Marín-García J, Goldenthal MJ, Flores-Sarnat L, Sarnat HB (2002) Severe mitochondrial cytopathy with complete A-V block, PEO, and mtDNA deletions. Pediatr Neurol 27(3):213–216

    Article  PubMed  Google Scholar 

  24. Mazzaccara C, Iafusco D, Liguori R, Ferrigno M, Galderisi A, Vitale D, Simonelli F, Landolfo P, Prisco F, Masullo M, Sacchetti L (2012) Mitochondrial diabetes in children: seek and you will find it. PLoS One 7(4):e34956

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H, Cystic Fibrosis Related Diabetes Therapy Study Group (2009) Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 32(10):1783–1788

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Murphy R, Turnbull DM, Walker M, Hattersley AT (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A > G mitochondrial point mutation. Diabet Med 25(4):383–399

    Article  CAS  PubMed  Google Scholar 

  27. Naing A, Kenchaiah M, Krishnan B, Mir F, Charnley A, Egan C, Bano G (2014) Maternally inherited diabetes and deafness (MIDD): diagnosis and management. J Diabetes Complicat 28(4):542–546

    Article  PubMed  Google Scholar 

  28. Neustadt J, Pieczenik SR (2008) Medication-induced mitochondrial damage and disease. Mol Nutr Food Res 52(7):780–788

    Article  CAS  PubMed  Google Scholar 

  29. Olsson C, Zethelius B, Lagerström-Fermér M, Asplund J, Berne C, Landegren U (1998) Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum Mutat 12(1):52–58

    Article  CAS  PubMed  Google Scholar 

  30. Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(3):607–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Rewers MJ, Pillay K, Craig ME, Hanas R, Acerini CL, Maahs DM, International Society for Pediatric and Adolescent Diabetes (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 15(S20):102–114

    Article  CAS  PubMed  Google Scholar 

  32. Saneto RP, Sedensky MM (2013) Mitochondrial disease in childhood: mtDNA encoded. Neurotherapeutics 10(2):199–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Schaefer AM, Walker M, Turnbull DM, Taylor RW (2013) Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol 379(1-2):2–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Silvestre-Aillaud P, BenDahan D, Paquis-Fluckinger V, Pouget J, Pelissier JF, Desnuelle C, Cozzone PJ, Vialettes B (1995) Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA? Diabetologia 38(12):1485–1486

    Article  CAS  PubMed  Google Scholar 

  35. Stark R, Roden M (2007) ESCI Award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Investig 37(4):236–248

    Article  CAS  Google Scholar 

  36. Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M, Kasuga S, Satoh Y, Akai H, Toyota T (1998) The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 41(5):584–588

    Article  CAS  PubMed  Google Scholar 

  37. Szendroedi J, Schmid AI, Meyerspeer M, Cervin C, Kacerovsky M, Smekal G, Gräser-Lang S, Groop L, Roden M (2009) Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 32(4):677–679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Takeshima T, Nakashima K (2005) MIDD and MELAS: a clinical spectrum. Intern Med 44(4):276–277

    Article  PubMed  Google Scholar 

  39. Tang X, Luo YX, Chen HZ, Liu DP (2014) Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 5:175

    Article  PubMed  PubMed Central  Google Scholar 

  40. Turner N, Heilbronn LK (2008) Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19(9):324–330

    Article  CAS  PubMed  Google Scholar 

  41. van Essen EH, Roep BO, ‘t Hart LM, Jansen JJ, Van den Ouweland JM, Lemkes HH, Maassen JA (2000) HLA-DQ polymorphism and degree of heteroplasmy of the A3243G mitochondrial DNA mutation in maternally inherited diabetes and deafness. Diabet Med 17(12):841–847

    Article  PubMed  Google Scholar 

  42. Velho G, Byrne MM, Clément K, Sturis J, Pueyo ME, Blanché H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P (1996) Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes 45(4):478–487

    Article  CAS  PubMed  Google Scholar 

  43. Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089

    Article  CAS  PubMed  Google Scholar 

Download references

Authors’ contributions

CR, TM and RWH wrote the manuscript. EB and RWH performed statistical analysis. AT, PMH, HH, EB, WM clinically managed the patients and critically reviewed the manuscript together with MR and EB. All the authors approved the final copy of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina Reinauer.

Ethics declarations

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The DPV has the ethical approval at the University of Ulm. Data collection was approved by the local institutional review boards.

Funding

The DPV database is supported by the German Federal Ministry of Education and Research (BMBF) as part of the Competence Network for Diabetes mellitus (Kompetenznetz Diabetes mellitus, FKZ 01GI1106), which was integrated into the German Center for Diabetes Research (DZD) in 2015, the German Diabetes Association (Deutsche Diabetes Gesellschaft, DDG), the European Foundation for the Study of Diabetes (EFSD), and the Heinz Bürger-Büsing Foundation.

Conflict of interest

The authors declare that they have no competing interests.

The DPV initiative received grant support from Sanofi Aventis, Lilly, Novo Nordisk, Boehringer Ingelheim, Roche Diagnostics and Medtronic. None of these grants is related to the present study.

Additional information

Communicated by Beat Steinmann

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 34 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reinauer, C., Meissner, T., Roden, M. et al. Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry. Eur J Pediatr 175, 613–622 (2016). https://doi.org/10.1007/s00431-015-2675-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-015-2675-5

Keywords

Navigation